Skip to main content
All lobbying filings

COHERUS BIOSCIENCES

Lobbying for COHERUS BIOSCIENCES, INC.

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Aug 18, 2025
Expenses
$125,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • DAVID SANDERS
    Previously held: Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 18
  • Centers For Medicare and Medicaid Services (CMS)
  • Commerce, Dept of (DOC)
  • Defense Advanced Research Projects Agency (DARPA)
  • Defense, Dept of (DOD)
  • Defense Nuclear Facilities Safety Board
  • Energy, Dept of
  • Executive Office of the President (EOP)
  • Federal Emergency Management Agency (FEMA)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • Office of Science & Technology Policy (OSTP)
  • President of the U.S.
  • SENATE
  • Vice President of the U.S.
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act

Government Issues

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem